Protein crystallization strategies in structure-based drug design
- 24 December 2025
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Discovery
- Vol. 21 (2) , 201-217
Abstract
Efficient structure-based design requires robust protocols for generating protein-ligand complex structures to support iterative chemical optimization. However, developing reliable crystallization conditions suitable for drug discovery remains challenging, especially for novel targets and when working with diverse ligand classes. The review focuses on establishing robust crystallization workflows and providing solutions when standard methods prove inadequate for obtaining protein-ligand crystal structures. In addition to reviewing the literature for generic technical advances, the authors provide a comprehensive overview of project- and protein-specific approaches. To further substantiate their claims, the authors analyzed metadata from their proprietary structure collection, representing 20 years of crystallography supporting structure-based drug design. The authors provide two detailed examples showcasing rescue strategies in action. Crystal structures will remain fundamental to structure-based drug design moving forward. Successful crystallization demands adaptable, multi-faceted strategies that systematically explore diverse protein variants and crystallization conditions. Future progress depends on integrating AI tools for construct design with project insights and robust experimental workflows. Success ultimately hinges on synergy between innovative problem-solving approaches and deep expertise in navigating this rapidly evolving landscape.Keywords
This publication has 126 references indexed in Scilit:
- Accelerating Drug Discovery With High‐Throughput Crystallographic Fragment Screening and Structural EnablementApplied Research, 2024
- Systematic enhancement of protein crystallization efficiency by bulk lysine‐to‐arginine (KR) substitutionProtein Science, 2024
- Screening and Production of Recombinant Human Proteins: Protein Production in E. coli2020
- Two Methods, One Goal: Structural Differences between Cocrystallization and Crystal Soaking to Discover Ligand Binding PosesChemMedChem, 2020
- An Industrial Perspective on Protein–Ligand Complex Crystallization2020
- Protein Crystallization2017
- Fragment Screening of Soluble Epoxide Hydrolase for Lead Generation—Structure‐Based Hit Evaluation and Chemistry ExplorationChemMedChem, 2016
- Benzoxazepines Achieve Potent Suppression of IL‐17 Release in Human T‐Helper 17 (TH17) Cells through an Induced‐Fit Binding Mode to the Nuclear Receptor RORγChemMedChem, 2015
- Screening Ligands by X-ray Crystallography2014
- Structural Analysis of Phenothiazine Derivatives as Allosteric Inhibitors of the MALT1 ParacaspaseAngewandte Chemie International Edition, 2013